The water extract obtained from the aerial parts of Sideritis euboea (Lamiaceae), which is known in Greece as ‘mountain tea’, was investigated by determining the in vitro effect of this extract on the IL-6, OPG and RANKL secretion by osteoblasts, three important molecules in osteoblast-osteoclast interplay. The results showed that this extract reduced significantly the secretion of IL-6 by KS-483 osteoblasts, while it also suppressed RANKL secretion, with both effects being dose-dependent and more potent at the higher concentrations tested (50, 100 μg/mL). We further determined the chemical profile of the extract by applying an analytical U-HPLC-DAD-ESIMS/MS method using the high resolution hybrid LTQ-Orbitrap Discovery spectrometer. An ESI source in negative mode was employed. The analysis indicated that the water extract of S. euboea is rich in flavonoid glycosides, and phenylpropanoid glycosides.
VegaD, MaaloufNM, SakhaeeK. (2007) CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications. Journal of Clinical Endocrinology and Metabolism, 92, 4514–4521.
2.
JilkaRL, HangocG, GirasoleG, PasseriG, WilliamsDC, AbramsJS, BoyceB, BroxmeyerH, ManolagasSC (1992) Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science, 257, 88–91.
3.
KanisJA, BurletN, CooperC, DelmasPD, ReginsterJY, BorgstromF, RizzoliR. (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 19, 399–428.
4.
OnoY, FukayaY, ImaiS, YamakuniT. (2008) Beneficial effects of Ajuga decumbens on osteoporosis and arthritis. Biological & Pharmaceutical Bulletin, 31, 1199–1204.
5.
ChaeHJ, ChaeSW, YunDH, KeumKS, YooSK, KimHR. (2004) Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts. Immunopharmacology and Immunotoxicology, 26, 135–144.
6.
DontasI, HalabalakiM, MoutsatsouP, MitakouS, PapoutsiZ, KhaldiL, GalanosA, LyritisGP. (2006) Protective effect of plant extract from Onobrychis ebenoides on ovariectomy-induced bone loss in rats. Maturitas, 53, 234–242.
7.
Obon de CastroC, Rivera-NunezD. (1994) A taxonomic revision of the Section Sideritis (Genus Sideritis) (Labiatae), J. Cramer, Berlin-Stuttgart.
8.
ErtasA, OzturkM, BogaM, TopcuG. (2009) Antioxidant and anticholinesterase activity evaluation of ent-kaurane diterpenoids from Sideritis arguta. Journal of Natural Products, 72, 500–502.
9.
DiazRM, Garcia-GranadosA, MorenoE, ParraA, Quevedo-SarmientoJ, Saenz deBA, Saenz de BuruagaJM. (1988) Studies on the relationship of structure to antimicrobial properties of diterpenoid compounds from Sideritis. Planta Medica, 54, 301–304.
TsaknisJ, LalasS. (2005) Extraction and identification of natural antioxidant from Sideritis euboea (mountain tea). Journal of Agricultural and Food Chemistry, 53, 6375–6381.
12.
KupeliE, SahinFP, CalisI, YesiladaE, EzerN. (2007) Phenolic compounds of Sideritis ozturkii and their in vivo anti-inflammatory and antinociceptive activities. Journal of Ethnopharmacology, 112, 356–360.
13.
MenghiniL, MassarelliP, BruniG, MenghiniA. (2005) Preliminary evaluation on anti-inflammatory and analgesic effects of Sideritis syriaca L. herba extracts. Journal of Medicinal Food, 8, 227–231.
14.
StridA, TanK (1991) Mountain Flora of Greece Vol II: 84–91. Edinburgh, Edinburgh University Press.
FragaBM, HernandezMG, FernandezC, SantanaJM. (2009) A chemotaxonomic study of nine Canarian Sideritis species. Phytochemistry, 70, 1038–1048.
17.
AlipievaKI, KostadinovaEP, EvstatievaLN, StefovaM, BankovaVS. (2009) An iridoid and a flavonoid from Sideritis lanata L. Fitoterapia, 80, 51–53.
18.
KupeliE, SahinFP, YesiladaE, CalisI, EzerN. (2007) In vivo anti-inflammatory and antinociceptive activity evaluation of phenolic compounds from Sideritis stricta. Zeitschrift für Naturforschung: C, A Journal of Biosciences, 62, 519–525.
19.
GabrieliCN, KefalasPG, KokkalouEL. (2005) Antioxidant activity of flavonoids from Sideritis raeseri. Journal of Ethnopharmacology, 96, 423–428.
20.
JaneskaB, StefovaM, AlipievaK. (2007) Assay of flavonoid aglycones from the species of genus Sideritis (Lamiaceae) from Macedonia with HPLC-UV DAD. Acta Pharmaceutica, 57, 371–377.
21.
SahinFP, TasdemirD, RuediP, EzerN, CalisI. (2004) Three acylated flavone glycosides from Sideritis ozturkii Aytac & Aksoy. Phytochemistry, 65, 2095–2099.
22.
ArmataA, GabrieliC, TermentziA, ZervouM, KokkalouE. (2008) Constituents of Sideritis syriaca ssp syriaca (Lamiaceae) and their antioxidant activity. Food Chemistry, 111, 179–186.
23.
DangZC, van BezooijenRL, KarperienM, PapapoulosSE, LowikCW. (2002) Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. Journal of Bone Mineral Research, 17, 394–405.
24.
CheungJ, MakYT, PapaioannouS, EvansBA, FogelmanI, HampsonG. (2003) Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. Journal of Endocrinology, 177, 423–433.
25.
KassemM, HarrisSA, SpelsbergTC, RiggsBL. (1996) Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors. Journal of Bone Mineral Research, 11, 193–199.
26.
HofbauerLC, KhoslaS, DunstanCR, LaceyDL, SpelsbergTC, RiggsBL. (1999) Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology, 140, 4367–4370.
27.
SaikaM, InoueD, KidoS, MatsumotoT. (2001) 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology, 142, 2205–2212.
28.
TarantaA, BramaM, TetiA, DelV, ScandurraR, SperaG, AgnusdeiD, TermineJD, MigliaccioS. (2002) The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro. Bone, 30, 368–376.
29.
LindbergMK, ErlandssonM, AlataloSL, WindahlS, AnderssonG, HalleenJM, CarlstenH, GustafssonJA, OhlssonC. (2001) Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice. Journal of Endocrinology, 171, 425–433.
30.
BuSY, HuntTS, SmithBJ. (2009) Dried plum polyphenols attenuate the detrimental effects of TNF-alpha on osteoblast function coincident with up-regulation of Runx2, Osterix and IGF-I. The Journal of Nutritional Biochemistry, 20, 35–44.
31.
ViereckV, GrundkerC, FriessS, FroschKH, RaddatzD, SchoppetM, NissleinT, EmonsG, HofbauerL. (2005) Isopropanolic extract of black cohosh stimulates OPG production by human osteoblasts. Journal of Bone and Mineral Research, 20, 2036–2043.
32.
YoonKD, JeongDG, HwangYH, RyuJM, KimJ. (2007) Inhibitors of osteoclast differentiation from Cephalotaxus koreana. Journal of Natural Products, 70, 2029–2032.
33.
ChenX, GarnerS, AndersonJ. (2002) Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochemical and Biophysical Research Communications, 295, 417–422.
